Overview

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Status:
Not yet recruiting

Trial end date:
2022-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the essential hypertension control.

Phase:

Phase 3

Details

Lead Sponsor:

EMS

Treatments:

Chlorthalidone
Hydrochlorothiazide
Losartan
Olmesartan
Olmesartan Medoxomil